Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
34.07
-0.09 (-0.26%)
At close: May 22, 2026, 4:00 PM EDT
34.00
-0.07 (-0.20%)
After-hours: May 22, 2026, 7:00 PM EDT

Teva Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
39,67235,88624,99011,70410,1328,838
Market Cap Growth
91.42%43.60%113.51%15.51%14.65%-16.48%
Enterprise Value
52,85649,42840,11629,25129,68631,098
Last Close Price
34.0731.2122.0410.449.128.01
PE Ratio
25.4425.79---21.08
Forward PE
14.1412.078.354.213.633.02
PEG Ratio
3.471.826.690.401.630.68
PS Ratio
2.292.081.510.740.680.56
PB Ratio
4.824.544.651.561.300.86
P/TBV Ratio
4.844.594.641.561.300.86
P/FCF Ratio
33.8531.2633.3613.909.7237.45
P/OCF Ratio
23.1521.7620.048.566.3711.07
EV/Sales Ratio
3.052.862.421.851.991.96
EV/EBITDA Ratio
10.5615.5553.9919.04-10.21
EV/EBIT Ratio
13.1922.71-76.37-18.13
EV/FCF Ratio
45.1043.0653.5634.7428.49131.77
Debt / Equity Ratio
2.052.163.162.482.512.09
Debt / EBITDA Ratio
4.245.3824.3313.12-7.70
Debt / FCF Ratio
14.4314.8924.1423.9420.6999.40
Net Debt / Equity Ratio
1.601.712.752.262.402.07
Net Debt / EBITDA Ratio
3.304.2619.8911.02-18.836.99
Net Debt / FCF Ratio
11.2311.7919.7320.1018.0090.23
Asset Turnover
0.430.430.400.360.330.32
Inventory Turnover
2.622.692.412.092.082.02
Quick Ratio
0.530.540.500.540.570.61
Current Ratio
1.011.040.981.021.051.14
Return on Equity (ROE)
19.22%20.58%-28.31%-7.38%-25.40%4.01%
Return on Assets (ROA)
8.41%6.23%-1.17%0.87%-4.00%2.37%
Return on Invested Capital (ROIC)
12.60%9.28%-1.68%1.19%-5.27%3.06%
Return on Capital Employed (ROCE)
11.11%8.09%-1.09%1.20%-6.66%4.63%
Earnings Yield
3.94%3.88%---4.74%
FCF Yield
2.95%3.20%3.00%7.19%10.28%2.67%
Buyback Yield / Dilution
-2.93%-2.83%-1.07%-0.81%-0.27%-1.10%
Total Shareholder Return
-2.93%-2.83%-1.07%-0.81%-0.27%-1.10%
Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q